AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2016
Jan 6, 2016
31523_dirs_2016-01-06_fb39af8f-5c49-40d3-874a-8e061b397ff0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-12-03
Reporting Person: Barth Jay (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-03 | Common stock | M | 25000 | — | Acquired | 40687 | Direct |
| 2015-12-03 | Common stock | F | 9313 | $10.05 | Disposed | 31374 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-03 | Restricted stock units | $ | M | 25000 | Disposed | Common Stock (25000) | Direct | |
| 2016-01-04 | Stock Options (right to buy) | $9.03 | A | 90000 | Acquired | 2026-01-04 | Common Stock (90000) | Direct |
Footnotes
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: On April 10, 2014, the reporting person was granted 50,000 restricted stock units, vesting in equal installments of 25,000 restricted stock units on May 10, 2015 and 25,000 restricted stock units on December 3, 2015.
F3: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on January 4, 2017. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on February 1, 2017, with the final installment vesting on January 1, 2020.